slides · global inventory
Traction
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,471
Current window 5,311-5,340
Pages 350
Rows per page 30
Slide type
5,311-5,340 of 10,471
13
The slide uses a process flow diagram to present five key clinical outcomes.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
15
The slide uses a timeline-based visualization to demonstrate clinical efficacy.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
22
Includes fluorescence microscopy images as visual proof of biological activity (GFP expression) over time.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
23
Shows both in vivo (IP) and ex vivo (IM) imaging results with corresponding time-course data.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
20
The slide uses a trend line overlay on a bar chart to emphasize exponential growth.Nano Dimension | Investor Presentation Deck | 24 slides · Nano Dimension
Pitch deck Investor relations Beat · Team1 hit
21
The slide uses a before-after-framing approach to demonstrate M&A success.Nano Dimension | Investor Presentation Deck | 24 slides · Nano Dimension
Pitch deck Investor relations 1 hit
04
The slide uses a split-layout with metrics on the left and qualitative/quantitative highlights on the right.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Traction1 hit
06
The slide uses a human-centric photo of a local shopkeeper to reinforce the 'local business' and 'community' themes.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Traction1 hit
10
The chart illustrates that as neighborhood penetration increases, engagement growth increases, supporting the claim of network effects.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Product1 hit
12
The chart highlights Nextdoor in green and other major platforms in specific brand colors (Facebook blue, Snapchat yellow, Pinterest red).Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · Product1 hit
27
The slide uses a CAGR metric to highlight growth trends over specific periods.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
28
The slide uses two bar charts side-by-side to demonstrate consistent revenue growth over time.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
29
The slide shows two distinct bar charts side-by-side, one for annual data and one for quarterly data, with CAGR percentages highlighted.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
13
The slide uses dot plots for IC50 data and a bar chart for in vivo efficacy, highlighting NVL-520's performance.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
19
The chart displays dose-dependent exposure levels exceeding multiple target thresholds for ROS1 variants in CNS and periphery.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
20
Clinical trial data table showing efficacy metrics for a drug candidate.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
21
The chart uses a waterfall plot to visualize clinical efficacy, a standard in oncology drug development.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
22
The chart is a swimmer plot, commonly used in oncology clinical trials to visualize time-to-event data.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
23
Includes clinical trial data (ORR, tumor shrinkage, allele clearance) for a specific drug candidate.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
24
Includes MRI scan series showing lesion reduction over 8 weeks.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
31
The slide compares vehicle control against NVL-655 treatment in both bar chart (multiple models) and line chart (PDX model) formats.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
06
Uses two pie charts to illustrate growth over time.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · InterestLoop · Cost Of Inaction1 hit
07
Includes footnotes defining active partners and active programs.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · InterestLoop · Cost Of Inaction1 hit
09
The chart shows a steady upward trend in clinical programs, with the final bar representing Q1 2023.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · InterestLoop · Cost Of Inaction1 hit
10
OmniAb | Investor Presentation Deck | 39 slidesOmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · InterestLoop · Cost Of Inaction1 hit
24
The slide uses a screenshot of a conference presentation abstract as social proof/traction.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · DesireLoop · Quick Win Big Bet1 hit
25
The chart displays percentages for OmniRat (54%), Omniflic (26%), OmniChicken (14%), OmniClic (3%), and OmniMouse/OmniTaur (3% combined).OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
39
The slide uses a Gantt-style visualization to show the progression of drug candidates through clinical phases.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Action1 hit
07
The slide uses a hybrid timeline/area chart format to visualize revenue growth alongside qualitative milestones.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations Beat · Problem1 hit
11
The slide uses a numbered list format to display top-performing assets, followed by a summary metric box.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations Beat · Solution1 hit